Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Nyashadzaishe Mafirakureva"'
Autor:
Nyashadzaishe Mafirakureva, Sushant Mukherjee, Lise Denoeud-Ndam, Rose Otieno-Masaba, Boris Tchounga, Millicent Anyango Ouma, Stephen Siamba, Saint-Just Petnga, Patrice Tchendjou, Martina Casenghi, Appolinaire Tiam, Peter J Dodd
Publikováno v:
Journal of Global Health Reports, Vol 7 (2023)
# Background Elimination of catastrophic costs due to tuberculosis (TB) is one of the three targets of the World Health Organization (WHO) End TB Strategy. Limited data have yet been reported on the costs experienced by households of children receiv
Externí odkaz:
https://doaj.org/article/a5ea6803a90d4eeaae740b99849c0b5f
Autor:
Nyashadzaishe Mafirakureva, Sushant Mukherjee, Boris Tchounga, Daniel Atwine, Boris Tchakounte Youngui, Bob Ssekyanzi, Richard Okello, Simo Leonie, Jennifer Cohn, Martina Casenghi, Anca Vasiliu, Maryline Bonnet, Peter J Dodd
Publikováno v:
Journal of Global Health Reports, Vol 7 (2023)
# Background Tuberculosis preventive treatment (TPT) in child household contacts is recommended by World Health Organization (WHO) but limited data has been reported on the costs experienced by households with children receiving TPT. # Methods We
Externí odkaz:
https://doaj.org/article/0563cfdadb464a069ddff30b86f7664e
Autor:
Nyashadzaishe Mafirakureva, Sushant Mukherjee, Mikhael de Souza, Cassandra Kelly-Cirino, Mario J P Songane, Jennifer Cohn, Jean-François Lemaire, Martina Casenghi, Peter J Dodd
Publikováno v:
PLoS Medicine, Vol 20, Iss 9, p e1004285 (2023)
BackgroundOver 1 million children aged 0 to 14 years were estimated to develop tuberculosis in 2021, resulting in over 200,000 deaths. Practical interventions are urgently needed to improve diagnosis and antituberculosis treatment (ATT) initiation in
Externí odkaz:
https://doaj.org/article/90f186e72970414198c52296cc752291
Autor:
Geoff McCombe, Davina Swan, John S Lambert, Eileen O’Connor, Zoe Ward, Peter Vickerman, Gordana Avramovic, Des Crowley, Willard Tinago, Nyashadzaishe Mafirakureva, Walter Cullen
Publikováno v:
Interactive Journal of Medical Research, Vol 11, Iss 2, p e35300 (2022)
BackgroundHepatitis C virus (HCV) infection is common among people who inject drugs, yet well-described barriers mean that only a minority have accessed HCV treatment. Recent developments in HCV diagnosis and treatment facilitate innovative approache
Externí odkaz:
https://doaj.org/article/178389c0c0a64e6fbd6aec4a64c07054
Autor:
Peter J Dodd, Nyashadzaishe Mafirakureva, Rina Triasih, Debebe Shaweno, Jens Levy, Eveline Klinkenberg, Petra de Haas, Ineke Spruijt, Nastiti Kaswandani, Ahmed Bedru, Melaku Gebremichael, Edine W Tiemersma
Publikováno v:
BMJ Open, Vol 12, Iss 7 (2022)
Objectives The WHO currently recommends stool testing using GeneXpert MTB/Rif (Xpert) for the diagnosis of paediatric tuberculosis (TB). The simple one-step (SOS) stool method enables processing for Xpert testing at the primary healthcare (PHC) level
Externí odkaz:
https://doaj.org/article/49df7cf2e1f04e7db769c7a3d43e3e27
Autor:
Peter J Dodd, ProfPhD, Nyashadzaishe Mafirakureva, PhD, James A Seddon, PhD, Christopher F McQuaid, PhD
Publikováno v:
The Lancet Global Health, Vol 10, Iss 7, Pp e1034-e1044 (2022)
Summary: Background: Estimates suggest that at least 30 000 children develop multidrug-resistant or rifampicin-resistant tuberculosis each year. Despite household contact management (HCM) being widely recommended, it is rarely done. Methods: We used
Externí odkaz:
https://doaj.org/article/9afd514055dd408197aa6bf1998fdb60
Autor:
Peter Vickerman, Natasha K Martin, Adriane Wynn, Lara K Marquez, Antoine Chaillon, Kyi Pyar Soe, Derek C Johnson, Jean-Marc Zosso, Andrea Incerti, Anne Loarec, Aude Nguyen, Josephine G Walker, Nyashadzaishe Mafirakureva, Vincent Lo Re III, Craig McIntosh, Susan M Kiene, Stephanie Brodine, Richard S Garfein
Publikováno v:
BMJ Global Health, Vol 6, Iss 2 (2021)
Introduction Over half of those hepatitis C virus (HCV)/HIV coinfected live in low-income and middle-income countries, and many remain undiagnosed or untreated. In 2016, Médecins Sans Frontières (MSF) established a direct-acting antiviral (DAA) tre
Externí odkaz:
https://doaj.org/article/2bc809cc04474c6eae04bf3b01cf0b65
Autor:
Aaron G Lim, DPhil, Josephine G Walker, PhD, Nyashadzaishe Mafirakureva, PhD, Gul Ghuttai Khalid, MPH, Huma Qureshi, FRCP, Hassan Mahmood, FRSPH, Adam Trickey, PhD, Hannah Fraser, PhD, Khawar Aslam, MBBS, Gregoire Falq, MPH, Camille Fortas, MPH, Hassaan Zahid, MBBS, Ammara Naveed, MBBS, Rosa Auat, MD, Quaid Saeed, MPH, Charlotte F Davies, PhD, Christinah Mukandavire, PhD, Nancy Glass, MPH, David Maman, MD, Natasha K Martin, DPhil, Matthew Hickman, ProfPhD, Margaret T May, ProfPhD, Saeed Hamid, ProfFRCP, Anne Loarec, MD, Francisco Averhoff, MD, Peter Vickerman, ProfDPhil
Publikováno v:
The Lancet Global Health, Vol 8, Iss 3, Pp e440-e450 (2020)
Summary: Background: The WHO elimination strategy for hepatitis C virus advocates scaling up screening and treatment to reduce global hepatitis C incidence by 80% by 2030, but little is known about how this reduction could be achieved and the costs o
Externí odkaz:
https://doaj.org/article/52e9e7abd86245788c40fc6ac95606e9
Autor:
Jack Stone, Hannah Fraser, Josephine G. Walker, Nyashadzaishe Mafirakureva, Bernard Mundia, Charles Cleland, Kigen Bartilol, Helgar Musyoki, Wanjiru Waruiru, Allan Ragi, Parinita Bhattacharjee, Nok Chhun, John Lizcano, Matthew J. Akiyama, Peter Cherutich, Ernst Wisse, Ann Kurth, Niklas Luhmann, Peter Vickerman
Publikováno v:
AIDS. 36:2191-2201
People who inject drugs (PWID) in Kenya have high HIV (range across settings: 14-26%) and hepatitis C virus (HCV; 11-36%) prevalence. We evaluated the impact of existing and scaled-up interventions on HIV and HCV incidence among PWID in Kenya.HIV and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1914e1ae37353d8b98d3e14847c83391
https://doi.org/10.1097/qad.0000000000003382
https://doi.org/10.1097/qad.0000000000003382
Autor:
Blessing Dzingirai, Maarten J. Postma, Nyashadzaishe Mafirakureva, Leolin Katsidzira, Celia Moffat Joel Matyanga, Marinus van Hulst
Publikováno v:
Journal of Viral Hepatitis
Very few low‐income countries have developed national plans to achieve the viral hepatitis elimination targets set in the World Health Organization (WHO) strategy. We reviewed the policy environment, strategies and challenges on the fight against v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd841a9074306b4f1d796a908d03ee7
https://hdl.handle.net/11370/609ffbfd-fb14-457e-acc1-53a828883cdb
https://hdl.handle.net/11370/609ffbfd-fb14-457e-acc1-53a828883cdb